Erin Hunter


A New Approach to Treatment-Resistant C difficile Infection

Fecal microbiota transplant (FMT) is a promising option for patients struggling with CDI recurrences. But how can we ensure the treatment is successful?

Heidi Lee, PharmD


What’s New With Non–COVID-19 Vaccines

Although COVID-19 vaccination remains the primary focus for health care, other paramount vaccines need to be recognized. Here is a review.

Alex Peterson-Weber, PharmD


What Is a Better Treatment Approach for Immunocompromised Hosts With Clostridioides difficile Infection?

Here is a review of the effectiveness of fidaxomicin vs vancomycin for CDI treatment in populations with immunocompromised conditions.

Olivia F. Duffield, BS


Bad Bugs, New Drugs: A Discussion of Selected New Therapeutics From IDWeek 2022

Cefepimetaniborbactam may represent a safe and effective carbapenemsparing agent in cUTI and AP, whereas ridinilazole may play an important role in treating CDI.

Evelyn B. Villacorta Cari, MD


Sorry Ganciclovir, You’re Just Not the One for Me

Important clinical considerations to know about resistant CMV infections.

Joseph Reilly, BS, PharmD, BCGP


Key Takeaways on FMTs in the Treatment of CDI

Experts provide practice pearls for educating patients on and using FMTs for the management of CDI.

Jasmine R. Marcelin, MD, FACP, FIDSA


Invasive Nontyphoidal Salmonellosis: An Antimicrobial-Resistant Foe

Salmonella becomes more dangerous as antimicrobial resistance grows. Read about its most common manifestations.

Devin Weber, MD


Mixed Fungal Brain Abscess

Clinicians review a patient case including diagnosis, treatment, and follow-up.

Rana F. Hamdy, MD, MPH, MSCE


Improving Screening, Management of Hepatitis C in Infants and Children

Despite hepatitis C (HCV) incidence rates increasing, adequate screening for the virus continues to be a pressing challenge for public health officials.

Samira Zantout, PharmD, BCPS


Going Viral on Social Media: Integrating Digital Tools into Pharmacy Rotations

In the latest Bench to Bedside column, 2 clinicians discuss the benefits of utilizing social media for learning.

Nancy Reau, MD


The Future and Resources in HCV Care

Expert hepatologists discuss future developments in HCV that they are excited about and provide resources for new providers to get started on delivering HCV care.

Richard J. Hankins, MD


Reducing Peripheral Venous Catheter Infections

Lack of data may mean bloodstream infections caused by PVCs are an overlooked cause of morbidity in hospitalized patients.

Osama Hamdy, MD, PhD


Multidisciplinary Perspectives on HIV Treatment

A multidisciplinary panel concludes a discussion on best practices for managing patients with HIV in various healthcare settings and overcoming social health disparities.

Lillian Parr


Rising Dengue Fever Cases Carry One Health Implications

The increase highlights the threat posed by climate change and the need for innovative preparedness, prevention, and mitigation tools.

Jasanjeet Jawanda, MBBS


The Yin and Yang of Ceftolozane-Tazobactam Resistance Against Multidrug-Resistant Pseudomonas aeruginosa

Rates of hospital-onset multidrug-resistant P aeruginosa infections have increased significantly in recent years.

Dina Zheng, PharmD Candidate


What’s New in 2023 From the CLSI Subcommittee on Antimicrobial Susceptibility Testing

This year's Clinical and Laboratory Standards Institute (CLSI) Subcommittee on Antimicrobial Susceptibility Testing provided updated breakpoints on therapies.

Polly van den Berg, MD


Where Do We Draw the Line? Duration of Antibiotic Therapy Varies for Bloodstream Infections

With potential delays in treatment, bloodstream infections can be concerning for clinicians. Here is a review of the literature that offer guidance for treatment.

Joshua Fitch


Experts highlight common waterborne illnesses, preventive tips for summer

Experts emphasize prevalent waterborne illnesses and offer preventive advice for the summer season.

Tipu V. Khan, MD


The Future and Resources in HCV Care

Expert hepatologists discuss future developments in HCV that they are excited about and provide resources for new providers to get started on delivering HCV care.

Brian Ubhaus, PharmD


A Case of Candida Albicans Ventriculitis Secondary to E Coli Ventriculoperitoneal Shunt Infection

Rare cases of health care–associated meningitis and ventriculitis in adults caused by Candida species are associated with recent bacterial meningitis and broad-spectrum antibiotic use.

Marice Ruiz Conejo Castillo, MD


Challenges in the Management of Mycobacterium abscessus Complex

This pathogen is the third most frequently isolated nontuberculous mycobacteria seen in the United States. Here is a review of how it presents and treatment options.

Renslow Sherer, MD


Lessons in Resilience: What HIV Teaches Us About COVID-19

Four lessons learned from the AIDS crisis that can be applied to the fight against our current pandemic.

Bincy Abraham, MD, MS


Advice for Physicians to Manage C. Difficile Infection (CDI)

Experts share advice for physicians taking care of patients with C. difficile infection (CDI).

Walaiporn Wangchinda, MD


Sulbactam for Treatment of Carbapenem-Resistant Acinetobacter baumannii

This is a challenging pathogen, requiring pharmacokinetic and pharmacodynamic considerations; the recent FDA approval of sulbactam-durlobactam offers new hope.

Maureen Hennessey, PHD, CPCC, CPHQ


The Tripledemic as a Precursor to Stakeholder Alignment under the Quintuple Aim

Infectious disease outbreaks will continue to increase and trying to find strategies to ensure providers are cared for to prevent burnout and shortage staffing is essential if another pandemic arises.

Sara Rendell, PHD


Community-Acquired Candida Glabrata Empyema: An Atypical Diagnosis Not to Miss

Although this patient had none of these common risk factors associated with Candida empyema, she did have other factors predisposing her to fungal colonization and subsequent infection.

© 2024 MJH Life Sciences

All rights reserved.